Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SYLVIA NOBORE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Women's Health

NPI
1134580889
CMS profile
11190066
Location
VAN NUYS, CA

General Payments · PY2021–2024

$1,248.41

  • Reported across 58 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$325.85

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $325.85 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ViiV Healthcare Company $152.92 7
Gilead Sciences, Inc. $114.24 5
Merck Sharp & Dohme Corporation $41.56 2
PFIZER INC. $17.13 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $67.07 4
PY2022 $146.78 7
PY2023 $708.71 32
PY2024 $325.85 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Gilead Sciences, Inc. $22.17 01/10/2024 Food and Beverage Undisputed 01/23/2026 1133705094 CMS
Gilead Sciences, Inc. $17.30 02/15/2024 Food and Beverage Undisputed 01/23/2026 1133705096 CMS
Gilead Sciences, Inc. $19.56 03/05/2024 Food and Beverage Undisputed 01/23/2026 1133705098 CMS
Gilead Sciences, Inc. $33.21 04/17/2024 Food and Beverage Undisputed 01/23/2026 1133705100 CMS
Gilead Sciences, Inc. $22.00 05/02/2024 Food and Beverage Undisputed 01/23/2026 1133705102 CMS
Merck Sharp & Dohme LLC $19.38 03/27/2024 Food and Beverage Undisputed 01/23/2026 1141570886 CMS
Merck Sharp & Dohme LLC $22.18 12/09/2024 Food and Beverage Undisputed 01/23/2026 1141570910 CMS
PFIZER INC. $17.13 04/29/2024 Food and Beverage Undisputed 01/23/2026 1131411233 CMS
ViiV Healthcare Company $24.75 01/03/2024 Food and Beverage Undisputed 01/23/2026 1112778222 CMS
ViiV Healthcare Company $21.84 01/26/2024 Food and Beverage Undisputed 01/23/2026 1112730195 CMS
ViiV Healthcare Company $2.76 02/08/2024 Food and Beverage Undisputed 01/23/2026 1112767508 CMS
ViiV Healthcare Company $24.21 02/13/2024 Food and Beverage Undisputed 01/23/2026 1112727433 CMS
ViiV Healthcare Company $31.94 02/21/2024 Food and Beverage Undisputed 01/23/2026 1112739109 CMS
ViiV Healthcare Company $32.13 04/10/2024 Food and Beverage Undisputed 01/23/2026 1112812011 CMS
ViiV Healthcare Company $15.29 12/04/2024 Food and Beverage Undisputed 01/23/2026 1112756284 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.